Synucleinopathies from bench to bedside

https://doi.org/10.1016/S1353-8020(11)70010-4Get rights and content

Summary

Accumulation of alpha-synuclein is a pathological feature in several neurological diseases. Its characterization has allowed for a re-grouping of diseases according to the expected pathology. The clinical syndrome of PD can now be classified into forms with and without alpha-synuclein pathology. DLB and PDD are synucleinopathies, and MSA shows alpha-synuclein pathology with glial inclusions. ADHD symptoms commonly occur in persons that will subsequently develop DLB. A similar phenomenon may be the early personality changes and frontotemporal atrophy in patients with SNCA multiplication. RLS is not known to have alpha-synuclein pathology, but as PD and ADHD, involves a hypodopaminergic state. Furthermore, PD and RLS co-occur in families in a way that suggests common inheritance. A proportion of patients with ET have brainstem Lewy body pathology. Gaucher disease and other lysosomal storage disorders also have alpha-synuclein pathology. Alpha-synuclein is a naturally unfolded protein. Non-fibrillar oligomeres may be the toxic species, and Lewy body formation may in fact be protective. Inhibiting alpha-synuclein toxicity seems to be an attractive novel treatment strategy and several approaches are being developed. When such treatments become available, clinicians will need to be familiar with the clinical features that distinguish the synucleinopathies from their look-alikes.

References (20)

There are more references available in the full text version of this article.

Cited by (28)

  • Mutations in Niemann Pick type C gene are risk factor for Alzheimer's disease

    2014, Medical Hypotheses
    Citation Excerpt :

    The term synucleinopathies usually implies Parkinson’s disease (PD), dementia with Lewy bodies (DLB) and multiple system atrophy (MSA), even though this does not conclude the list. What these groups have in common are pathologic lesions composed of aggregates of insoluble α-synuclein protein in selectively vulnerable populations of neurons and glia [4,5]. Clinically, apart from parkinsonism and dementia, in this group of disorders olfactory disfunction, REM-sleep behavioral disorder and dysautonomia are interwoven [4,5].

  • Pesticides exposure as etiological factors of Parkinson's disease and other neurodegenerative diseases-A mechanistic approach

    2014, Toxicology Letters
    Citation Excerpt :

    In accordance, exposure to PQ was shown to induce m-aconitase-dependent increase in H2O2, Fe2+ and cell death as seen by the attenuation of H2O2 production when m-aconitase expression was reduced by RNA interference (Cantu et al., 2011). Progressive loss of DA neurons of the nigrostriatal system and deposition of filamentous α-synuclein aggregates are the main characteristics of PD (Puschmann et al., 2012). Indeed, besides the fact that α-synuclein is a natively unfolded protein that plays a central role in the control of synaptic membrane processes and biogenesis, when it becomes misfolded, it aggregates, and accumulates in neuronal inclusion bodies, the Lewy bodies (Bellucci et al., 2012).

  • EIF4G1 gene mutations are not a common cause of Parkinson's disease in the Japanese population

    2014, Parkinsonism and Related Disorders
    Citation Excerpt :

    Pathogenic mutations that result in hereditary forms of PD/parkinsonism are reported in a number of genes and have subsequently directed both functional studies and the generation of disease model systems [1,2]. The nomination of each new gene for parkinsonism implicates disease pathways and provides a rationale for targeted therapeutic development [3,4]. Recently, two substitutions in the eukaryotic translation initiation factor 4-gamma 1 protein (EIF4G1, MIM#600495); p.R1205H and p.A502V were nominated to cause PD with autosomal dominant inheritance in a number of pedigrees [5].

  • Genetic variants and animal models in SNCA and Parkinson disease

    2014, Ageing Research Reviews
    Citation Excerpt :

    It is prone to take on different conformations, depending on its surrounding microenvironment. It has a tendency to form microscopically visible dimers, oligomers, and various types of polymer aggregates, the hallmarks of the synucleinopathies (Puschmann et al., 2012). However, the most toxic form(s) of the α-synuclein protein to cells remains unclear (Saiki et al., 2012).

View all citing articles on Scopus
View full text